Skip to main content

Rare Disorders

0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
2 programs
AI systemN/A
AI-Assisted DiagnosisN/A
Autonomous Therapeutics
2 programs
AI systemN/A1 trial
AI-Assisted DiagnosisN/A1 trial
Active Trials
NCT07650799Not Yet Recruiting1,055Est. Dec 2027
NCT07625436Not Yet Recruiting150Est. Jun 2027
Alliance Pharmaceuticals
1 program
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordN/A1 trial
Active Trials
NCT01793168Recruiting20,000Est. Dec 2100

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Autonomous TherapeuticsAI system
Autonomous TherapeuticsAI-Assisted Diagnosis
Alliance PharmaceuticalsRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Clinical Trials (3)

Total enrollment: 21,205 patients across 3 trials

AI for Rare Disease Diagnosis in Real World

Start: Jun 2026Est. completion: Dec 20271,055 patients
N/ANot Yet Recruiting

Artificial Intelligence for Rare Disease Diagnosis

Start: Jun 2026Est. completion: Jun 2027150 patients
N/ANot Yet Recruiting
NCT01793168Alliance PharmaceuticalsRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Start: Jul 2010Est. completion: Dec 210020,000 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 21,205 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Rare Disorders | Pipeline & Competitive Landscape | Formulate